Play Live Radio
Next Up:
0:00 0:00
Available On Air Stations
Become a sustaining member today and you'll automatically unlock $200 in challenge funds!

N.H. Unhappy With Proposed Opioid Settlement from Purdue Pharma


The New Hampshire Attorney General's office is objecting to a proposed settlement offered by drug maker Purdue Pharma.

The maker of oxycontin is hoping to resolve thousands of lawsuits that allege the company played a major role in creating the opioid crisis.

The deal offered by Purdue is reported to be worth more than $10 billion and would involve the Sackler family giving up ownership of the company.

Many plaintiffs have signed on to the tentative deal. But a majority of state Attorneys General, including New Hampshire's, say it isn't good enough. James Boffetti with the New Hampshire AG's office says the deal doesn't offer nearly enough money to repair the damage done by opioids.

“It is simply a bad deal for New Hampshire and I think we need to hold out for a better deal,” said Boffetti.

“We want to continue to fight to basically reveal what this company has done and what their executives have done,” said Boffetti, “to shut down that company, and make them pay what they owe to our communities.”

The tentative settlement will need approval from a federal judge before moving forward.

Jason Moon is a senior reporter and producer on the Document team. He has created longform narrative podcast series on topics ranging from unsolved murders, to presidential elections, to secret lists of police officers.

You make NHPR possible.

NHPR is nonprofit and independent. We rely on readers like you to support the local, national, and international coverage on this website. Your support makes this news available to everyone.

Give today. A monthly donation of $5 makes a real difference.